HA
NTGN

HHLR Advisors’s Neon Therapeutics, Inc. Common Stock NTGN Stock Holding History

HHLR Advisors’s Portfolio NTGN Stock Details NTGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-60,000
Closed -$103K – 69
2019
Q3 		$103K Buy
+60,000
New +$183K ﹤0.01% 64
2019
Q1 		– Sell
-312,500
Closed -$1.57M – 35
2018
Q4 		$1.57M Buy
+312,500
New +$2.19M 0.07% 31

Other funds holding NTGN

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HHLR Advisors's NTGN Position: Q4 2019 in Review

HHLR Advisors sold out of Neon Therapeutics, Inc. Common Stock (NTGN) in Q4 2019, closing a stake of 60,000 shares — an estimated $103K sold.

HHLR Advisors first reported a position in NTGN in Q4 2018 and held it in 2 quarters. The position peaked at $1.57M in Q4 2018. 46 funds tracked by Wall St. Rank hold NTGN as of Q4 2019.

  • HHLR Advisors reported no remaining Neon Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • HHLR Advisors sold 60,000 Neon Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $103K.
  • HHLR Advisors first reported a position in Neon Therapeutics, Inc. Common Stock in Q4 2018 and held it in 2 quarters.
  • HHLR Advisors's Neon Therapeutics, Inc. Common Stock position peaked at $1.57M in Q4 2018.
  • 46 funds tracked by Wall St. Rank held Neon Therapeutics, Inc. Common Stock as of Q4 2019.

Based on HHLR Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.